Meng Xu

机构：King Center, Second Affiliated Hospital of Xi'an Jiaotong University, Center for Life Sciences, Tsinghua University · ORCID：0000-0002-6118-9965

发表论文 235 篇 · 总被引 11915 次 · h-index 46

代表论文

• PRECISE-seq reveals disease-relevant TCR repertoires with phenotypic plasticity (2026 · The Journal of Experimental Medicine · 被引 2)
• Ultra-precision deconvolution of spatial transcriptomics decodes immune heterogeneity and fate-defining programs in tissues (2026 · Nature Communications · 被引 2)
• Distinct molecular pathways regulated by activated AKT and YAP signaling during intrahepatic cholangiocarcinoma progression (2026 · Journal of Hepatology · 被引 2)
• Data from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma (2025 · 被引 1)
• A new regulatory axis in cross-presentation: MS4A7 licenses cDC1s for effective CD8+ T-cell priming (2026 · Science China Life Sciences)
• Supplementary Figure S5 from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma (2025)